Zilia, a Quebec Metropolis, Canada-based medical know-how firm, raised an undisclosed quantity in bridge funding.
Backers included Linearis Ventures.
The corporate intends to make use of the funds to scale commercialization of its flagship know-how, the Zilia Ocular.
Led by CEO Patrick Sauvageau, Zilia is a medical know-how firm creating a platform to non-invasively measure biomarkers within the eye, with an preliminary give attention to ocular oximetry. By integrating photonics and synthetic intelligence, its know-how is meant to leverage the attention’s optical properties and direct connections to the vascular system and the mind, capturing vital info on ocular and general well being.
FinSMEs
07/05/2025
